NYSE:ELMD Electromed (ELMD) Stock Price, News & Analysis → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free ELMD Stock Alerts $15.93 -0.80 (-4.78%) (As of 09:38 AM ET) Add Compare Share Share Today's Range$15.93▼$16.7750-Day Range$13.47▼$17.6152-Week Range$8.80▼$17.85Volume4,596 shsAverage Volume28,368 shsMarket Capitalization$137.16 millionP/E Ratio35.40Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media Get Electromed alerts: Email Address Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Electromed Stock (NYSE:ELMD)Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care and institutional markets for patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases. It markets its products primarily to physicians and health care providers, as well as directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.Read More ELMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ELMD Stock News HeadlinesApril 23, 2024 | finance.yahoo.comElectromed, Inc. Schedules its Third Quarter Fiscal 2024 Financial Results Conference Call for May 7, 2024 at 5:00 p.m. ETApril 23, 2024 | businesswire.comElectromed, Inc. Schedules its Third Quarter Fiscal 2024 Financial Results Conference Call for May 7, 2024 at 5:00 p.m. ETApril 25, 2024 | TradeSmith (Ad)The A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...April 18, 2024 | americanbankingnews.comElectromed (NYSE:ELMD) Stock Rating Lowered by StockNews.comApril 8, 2024 | businesswire.comElectromed, Inc. to Participate in the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity ConferenceMarch 11, 2024 | msn.comClearPoint Neuro Q4 2023 Earnings PreviewFebruary 28, 2024 | businesswire.comElectromed, Inc. to Participate in the 2024 Sidoti March Small-Cap Virtual ConferenceFebruary 23, 2024 | finance.yahoo.comELMD Aug 2024 7.500 putApril 25, 2024 | TradeSmith (Ad)The A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...February 23, 2024 | finance.yahoo.comELMD May 2024 10.000 callFebruary 22, 2024 | benzinga.comElectromed Stock (AMEX:ELMD) Earnings Dates and Earning CallsFebruary 14, 2024 | finance.yahoo.comElectromed, Inc. (AMEX:ELMD) Q2 2024 Earnings Call TranscriptFebruary 13, 2024 | benzinga.comRecap: Electromed Q2 EarningsFebruary 13, 2024 | finance.yahoo.comElectromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second QuarterFebruary 13, 2024 | wsj.comElectromed Inc.February 12, 2024 | benzinga.comEarnings Outlook For ElectromedJanuary 29, 2024 | finance.yahoo.comElectromed, Inc. Announces Partnership to Expand SmartVest Access to Veterans, Federal Employees, and Native American CommunitiesDecember 28, 2023 | msn.comDawson James sees Cytosorbents' Cytosorb as approvable, but raises riskDecember 28, 2023 | msn.comCytoSorbents drops as blood purification system fails key trialDecember 18, 2023 | seekingalpha.comElectromed director Andrew Summers purchases shares worth ~$302.4KNovember 9, 2023 | insidermonkey.comElectromed, Inc. (AMEX:ELMD) Q1 2024 Earnings Call TranscriptNovember 7, 2023 | msn.comElectromed GAAP EPS of $0.02, revenue of $12.3MNovember 7, 2023 | finance.yahoo.comElectromed, Inc. Announces Fiscal 2024 First Quarter Financial ResultsNovember 7, 2023 | finance.yahoo.comElectromed Inc (ELMD) Reports 16% Revenue Growth in Q1 FY 2024November 6, 2023 | markets.businessinsider.comElectromed is about to announce its earnings — here's what Wall Street expectsNovember 1, 2023 | finance.yahoo.comElectromed, Inc. to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumOctober 24, 2023 | businesswire.comElectromed, Inc. Schedules its First Quarter Fiscal 2024 Financial Results Conference Call for November 7, 2023 at 5:00 p.m. ETSee More Headlines Receive ELMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Electromed and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/13/2024Today4/25/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNYSE:ELMD CUSIPN/A CIK1488917 Websmartvest.com Phone(952) 758-9299Fax866-758-5077Employees170Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.45 Trailing P/E Ratio36.45 Forward P/E RatioN/A P/E GrowthN/ANet Income$3.17 million Net Margins7.62% Pretax Margin10.32% Return on Equity10.32% Return on Assets8.76% Debt Debt-to-Equity RatioN/A Current Ratio5.97 Quick Ratio5.25 Sales & Book Value Annual Sales$48.07 million Price / Sales2.94 Cash Flow$0.46 per share Price / Cash Flow35.61 Book Value$4.40 per share Price / Book3.73Miscellaneous Outstanding Shares8,610,000Free Float7,512,000Market Cap$141.20 million OptionableOptionable Beta0.43 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Bradley M. Nagel (Age 42)Chief Financial Officer Comp: $288.73kMr. James L. Cunniff (Age 58)President, Director & CEO Mr. William J. George (Age 75)Secretary Key CompetitorsOutset MedicalNASDAQ:OMFONARNASDAQ:FONRVivani MedicalNASDAQ:VANISemler ScientificNASDAQ:SMLRHyperfineNASDAQ:HYPRView All CompetitorsInsiders & InstitutionsCorsair Capital Management L.P.Sold 1,800 shares on 2/14/2024Ownership: 0.173%White Pine Capital LLCSold 36,028 shares on 2/5/2024Ownership: 0.497%Kathleen SkarvanSold 1,107 sharesTotal: $11,988.81 ($10.83/share)View All Insider TransactionsView All Institutional Transactions ELMD Stock Analysis - Frequently Asked Questions How have ELMD shares performed in 2024? Electromed's stock was trading at $10.91 at the beginning of 2024. Since then, ELMD shares have increased by 46.0% and is now trading at $15.93. View the best growth stocks for 2024 here. How were Electromed's earnings last quarter? Electromed, Inc. (NYSE:ELMD) released its quarterly earnings data on Tuesday, February, 13th. The company reported $0.19 earnings per share (EPS) for the quarter. The company had revenue of $13.69 million for the quarter. Electromed had a net margin of 7.62% and a trailing twelve-month return on equity of 10.32%. How do I buy shares of Electromed? Shares of ELMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:ELMD) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Electromed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
